Mechanistic Implications and Characterization of Anaplastic Lymphoma Kinase (ALK) mutations in Neuroblastoma
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that was first reported as a fusion partner of nucleophosmin in Anaplastic large cell lymphoma in 1994. ALK is involved in myriad of cancers including neuroblastoma which is the most common extracranial solid tumor affecting young childr...
Main Author: | Chand, Damini |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Umeå universitet, Institutionen för molekylärbiologi (Medicinska fakulteten)
2015
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-106663 http://nbn-resolving.de/urn:isbn:978-91-7601-254-3 |
Similar Items
-
Alectinib, an Anaplastic Lymphoma Kinase Inhibitor, Abolishes ALK Activity and Growth in ALK-Positive Neuroblastoma Cells
by: Muhammad Wasi Alam, et al.
Published: (2019-07-01) -
Role and targeting of anaplastic lymphoma kinase in cancer
by: Carminia Maria Della Corte, et al.
Published: (2018-02-01) -
Novel Molecular Challenges in Targeting Anaplastic Lymphoma Kinase in ALK-Expressing Human Cancers
by: Abdulraheem Alshareef
Published: (2017-10-01) -
P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer
by: Ryohei Katayama, et al.
Published: (2016-01-01) -
ALK in Neuroblastoma: Biological and Therapeutic Implications
by: Ricky M. Trigg, et al.
Published: (2018-04-01)